Stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer: Comparing survival outcomes in adenocarcinoma and squamous cell carcinoma
Stephen Abel, Shaakir Hasan, Richard White et al. · Lung Cancer · 2018
Cited by 35 works. doi:10.1016/j.lungcan.2018.12.022
Authors
References
- Statistical power analysis for the behavioral sciences
- Statistical Power Analysis for the Behavioral Sciences
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
- Statistical Power Analysis for the Behavioral Sciences
- Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
- AJCC Cancer Staging Manual
- Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer
- Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study
- Non-small-cell lung cancers: a heterogeneous set of diseases